1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	639_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	639_QUEST_clinical_caseMIR	SENT1	-	-
3	45	45		-	-	9-11	639_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	639_QUEST_clinical_caseMIR	SENT1	-	-
5	sin	sin	SPS00	C0332122_1	calificador_1	17-20	639_QUEST_clinical_caseMIR	SENT1	-	-
6	antecedentes	antecedente	NCMP000	C0332122_2	calificador_2	21-33	639_QUEST_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332122_3	calificador_3	34-36	639_QUEST_clinical_caseMIR	SENT1	-	-
8	interés	interés	NCMS000	-	-	37-44	639_QUEST_clinical_caseMIR	SENT1	-	-
9	,	,	Fc	-	-	44-45	639_QUEST_clinical_caseMIR	SENT1	-	-
10	con	con	SPS00	C0332287	atributo	46-49	639_QUEST_clinical_caseMIR	SENT1	-	-
11	el	el	DA0MS0	-	-	50-52	639_QUEST_clinical_caseMIR	SENT1	-	-
12	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	53-64	639_QUEST_clinical_caseMIR	SENT1	-	-
13	de	de	SPS00	C0332285	atributo	65-67	639_QUEST_clinical_caseMIR	SENT1	-	-
14	cáncer	cáncer	NCMS000	C1306459#C0936282#C0006826	anomalía_morfológica#trastorno	68-74	639_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	de	de	SPS00	C0332285	atributo	75-77	639_QUEST_clinical_caseMIR	SENT1	-	-
16	colon	colon	NCMS000	C0009368#C1281569	estructura_corporal	78-83	639_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
17	con	con	SPS00	C0332287	atributo	84-87	639_QUEST_clinical_caseMIR	SENT1	-	-
18	afectación	afectación	NCFS000	-	-	88-98	639_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
19	hepática	hepático	AQ0FS0	-	-	99-107	639_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
20	,	,	Fc	-	-	107-108	639_QUEST_clinical_caseMIR	SENT1	-	-
21	con	con	SPS00	C0332287	atributo	109-112	639_QUEST_clinical_caseMIR	SENT1	-	-
22	buen	bueno	AQ0MS0	C0205170	calificador	113-117	639_QUEST_clinical_caseMIR	SENT1	-	-
23	estado	estado	NCMS000	C0449438#C1301808	atributo#medio_ambiente	118-124	639_QUEST_clinical_caseMIR	SENT1	-	-
24	general	general	AQ0CS0	C0205246	calificador	125-132	639_QUEST_clinical_caseMIR	SENT1	-	-
25	,	,	Fc	-	-	132-133	639_QUEST_clinical_caseMIR	SENT1	-	-
26	sin	sin	SPS00	C0332288	atributo	134-137	639_QUEST_clinical_caseMIR	SENT1	-	-
27	alteraciones	alteración	NCFP000	-	-	138-150	639_QUEST_clinical_caseMIR	SENT1	-	Negacion
28	analíticas	analítico	AQ0FP0	-	-	151-161	639_QUEST_clinical_caseMIR	SENT1	-	-
29	.	.	Fp	-	-	161-162	639_QUEST_clinical_caseMIR	SENT1	-	-

1	Comienza	comenzar	VMIP3S0	-	-	163-171	639_QUEST_clinical_caseMIR	SENT2	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	172-183	639_QUEST_clinical_caseMIR	SENT2	-	-
3	sistémico	sistémico	AQ0MS0	C0205373	calificador	184-193	639_QUEST_clinical_caseMIR	SENT2	-	-
4	paliativo	paliativo	NCMS000	-	-	194-203	639_QUEST_clinical_caseMIR	SENT2	-	-
5	en	en	SPS00	C1720294#C0332285	calificador#atributo	204-206	639_QUEST_clinical_caseMIR	SENT2	-	-
6	primera	1	AO0FS0	-	-	207-214	639_QUEST_clinical_caseMIR	SENT2	-	-
7	línea	línea	NCFS000	C0205132	calificador	215-220	639_QUEST_clinical_caseMIR	SENT2	-	-
8	con	con	SPS00	C0332287	atributo	221-224	639_QUEST_clinical_caseMIR	SENT2	-	-
9	oxaliplatino	oxaliplatino	NC00SC0	C0069717	sustancia#producto	225-237	639_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
10	,	,	Fc	-	-	237-238	639_QUEST_clinical_caseMIR	SENT2	-	-
11	5-fluoruracilo	5-fluoruracilo		-	-	239-253	639_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
12	y	y	CC	C1706368	calificador	254-255	639_QUEST_clinical_caseMIR	SENT2	-	-
13	bevacizumab	bevacizumab	NC00SC0	C0796392	producto#sustancia	256-267	639_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
14	,	,	Fc	-	-	267-268	639_QUEST_clinical_caseMIR	SENT2	-	-
15	sin	sin	SPS00	C0332288	atributo	269-272	639_QUEST_clinical_caseMIR	SENT2	-	-
16	ninguna	ninguno	DI0FS0	C0205160#C0549184	calificador	273-280	639_QUEST_clinical_caseMIR	SENT2	-	-
17	complicación	complicación	NCFS000	C0009566#C2362589	trastorno#atributo	281-293	639_QUEST_clinical_caseMIR	SENT2	-	-
18	.	.	Fp	-	-	293-294	639_QUEST_clinical_caseMIR	SENT2	-	-

1	Tras	tras	SPS00	-	-	295-299	639_QUEST_clinical_caseMIR	SENT3	-	-
2	4	4		-	-	300-301	639_QUEST_clinical_caseMIR	SENT3	-	-
3	meses	mes	NCMP000	C0439231	calificador	302-307	639_QUEST_clinical_caseMIR	SENT3	-	-
4	de	de	SPS00	C0332285	atributo	308-310	639_QUEST_clinical_caseMIR	SENT3	-	-
5	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	311-322	639_QUEST_clinical_caseMIR	SENT3	-	-
6	y	y	CC	C1706368	calificador	323-324	639_QUEST_clinical_caseMIR	SENT3	-	-
7	respuesta	respuesta	NCFS000	-	-	325-334	639_QUEST_clinical_caseMIR	SENT3	-	-
8	parcial	parcial	AQ0CS0	C0728938#C0205257#C0728939	calificador	335-342	639_QUEST_clinical_caseMIR	SENT3	-	-
9	de	de	SPS00	C0332285	atributo	343-345	639_QUEST_clinical_caseMIR	SENT3	-	-
10	la	el	DA0FS0	-	-	346-348	639_QUEST_clinical_caseMIR	SENT3	-	-
11	enfermedad	enfermedad	NCFS000	C0012634#C0039082	trastorno	349-359	639_QUEST_clinical_caseMIR	SENT3	-	-
12	,	,	Fc	-	-	359-360	639_QUEST_clinical_caseMIR	SENT3	-	-
13	acude	acudir	VMIP3S0	-	-	361-366	639_QUEST_clinical_caseMIR	SENT3	-	-
14	a	a	SPS00	-	-	367-368	639_QUEST_clinical_caseMIR	SENT3	-	-
15	Urgencias	urgencia	NCFP000	C0439609	calificador	369-378	639_QUEST_clinical_caseMIR	SENT3	-	-
16	por	por	SPS00	C0678226	atributo	379-382	639_QUEST_clinical_caseMIR	SENT3	-	-
17	cefalea	cefalea	NCFS000	C0018681	hallazgo	383-390	639_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
18	,	,	Fc	-	-	390-391	639_QUEST_clinical_caseMIR	SENT3	-	-
19	alteraciones	alteración	NCFP000	-	-	392-404	639_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
20	visuales	visual	AQ0CP0	C0234621	calificador	405-413	639_QUEST_clinical_caseMIR	SENT3	B-Calificador	-
21	,	,	Fc	-	-	413-414	639_QUEST_clinical_caseMIR	SENT3	-	-
22	tendencia	tendencia	NCFS000	-	-	415-424	639_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
23	al	al	SP+DA	-	-	425-427	639_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-
24	sueño	sueño	NCMS000	C0037313	entidad_observable	428-433	639_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-
25	e	y	CC	C1706368	calificador	434-435	639_QUEST_clinical_caseMIR	SENT3	-	-
26	hipertensión	hipertensión	NCFS000	C0020538_1	trastorno_1	436-448	639_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
27	arterial	arterial	NC00SC0	C0020538_2	trastorno_2	449-457	639_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
28	grave	grave	AQ0CS0	C0439808#C0205082	calificador	458-463	639_QUEST_clinical_caseMIR	SENT3	B-Calificador	-
29	.	.	Fp	-	-	463-464	639_QUEST_clinical_caseMIR	SENT3	-	-

1	Se	se	P00CN000	-	-	465-467	639_QUEST_clinical_caseMIR	SENT4	-	-
2	realiza	realizar	VMIP3S0	-	-	468-475	639_QUEST_clinical_caseMIR	SENT4	-	-
3	TC	símbolo_químico_del_tecnecio	NC00YL0	-	-	476-478	639_QUEST_clinical_caseMIR	SENT4	-	-
4	con	con	SPS00	C0332287	atributo	479-482	639_QUEST_clinical_caseMIR	SENT4	-	-
5	contraste	contraste	NCMS000	-	-	483-492	639_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
6	intravenoso	intravenoso	AQ0MS0	C0348016	calificador	493-504	639_QUEST_clinical_caseMIR	SENT4	-	-
7	y	y	CC	C1706368	calificador	505-506	639_QUEST_clinical_caseMIR	SENT4	-	-
8	se	se	P00CN000	-	-	507-509	639_QUEST_clinical_caseMIR	SENT4	-	-
9	evidencia	evidenciar	VMIP3S0	-	-	510-519	639_QUEST_clinical_caseMIR	SENT4	-	-
10	una	una		C0205447_1	calificador_1	520-523	639_QUEST_clinical_caseMIR	SENT4	-	-
11	alteración	alteración	NCFS000	-	-	524-534	639_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
12	bilateral	bilateral	AQ0CS0	C0238767	calificador	535-544	639_QUEST_clinical_caseMIR	SENT4	B-Calificador	-
13	extensa	extenso	AQ0FS0	-	-	545-552	639_QUEST_clinical_caseMIR	SENT4	B-Calificador	-
14	en	en	SPS00	C1720294#C0332285	calificador#atributo	553-555	639_QUEST_clinical_caseMIR	SENT4	-	-
15	la	el	DA0FS0	-	-	556-558	639_QUEST_clinical_caseMIR	SENT4	-	-
16	sustancia	sustancia	NCFS000	C0439861	sustancia#atributo	559-568	639_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
17	blanca	blanco	AQ0FS0	C0220938	calificador	569-575	639_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-
18	con	con	SPS00	C0332287	atributo	576-579	639_QUEST_clinical_caseMIR	SENT4	-	-
19	edema	edema	NCMS000	C0006114#C1527311_1	trastorno_1	580-585	639_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
20	cerebral	cerebral	NCCS000	C0006114#C1527311_2	trastorno_2	586-594	639_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
21	en	en	SPS00	C1720294#C0332285	calificador#atributo	595-597	639_QUEST_clinical_caseMIR	SENT4	-	-
22	ambos	ambos	DI0MP0	C0238767	calificador	598-603	639_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
23	lóbulos	lóbulo	NCMP000	-	-	604-611	639_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-
24	occipitales	occipital	AQ0CP0	-	-	612-623	639_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-
25	y	y	CC	C1706368	calificador	624-625	639_QUEST_clinical_caseMIR	SENT4	-	-
26	en	en	SPS00	C1720294#C0332285	calificador#atributo	626-628	639_QUEST_clinical_caseMIR	SENT4	-	-
27	cerebelo	cerebelo	NCMS000	C0007765#C1268981	estructura_corporal	629-637	639_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
28	.	.	Fp	-	-	637-638	639_QUEST_clinical_caseMIR	SENT4	-	-

1	¿	¿	Fia	-	-	639-640	639_QUEST_clinical_caseMIR	SENT5	-	-
2	Cuál	cuál	PT0CS000	-	-	640-644	639_QUEST_clinical_caseMIR	SENT5	-	-
3	es	ser	VSIP3S0	-	-	645-647	639_QUEST_clinical_caseMIR	SENT5	-	-
4	la	el	DA0FS0	-	-	648-650	639_QUEST_clinical_caseMIR	SENT5	-	-
5	sospecha	sospechar	VMM02S0	C0332147_1	calificador_1	651-659	639_QUEST_clinical_caseMIR	SENT5	-	-
6	diagnóstica	diagnóstico	AQ0FS0	C0332147_2	calificador_2	660-671	639_QUEST_clinical_caseMIR	SENT5	-	-
7	más	más	RG	C0205172	calificador	672-675	639_QUEST_clinical_caseMIR	SENT5	-	-
8	probable	probable	AQ0CS0	C0332148	calificador	676-684	639_QUEST_clinical_caseMIR	SENT5	-	-
9	?	?	Fit	-	-	684-685	639_QUEST_clinical_caseMIR	SENT5	-	-
10	.	.	Fp	-	-	685-686	639_QUEST_clinical_caseMIR	SENT5	-	-

